Home › Agilent Technologies Collaborating With Weill Cornell Medical College To Advance Research In ALS
 

Keywords :   


Agilent Technologies Collaborating With Weill Cornell Medical College To Advance Research In ALS

2015-08-31 07:45:39| chemicalonline Home Page

Agilent Technologies Inc. recently announced it is collaborating with Dr. Steven Gross, a faculty member in the Department of Pharmacology at Weill Cornell Medical College, in New York, N.Y., to advance research in amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease

Tags: als research college medical

Category:Chemicals

Latest from this category

All news
14.05PPG Exhibits at The Battery Show
14.05BASF TotalEnergies Petrochemicals Installs STEAM Lab in Port Acres Elementary School
14.05SONGWON Announces 1Q 2024 Financial Results
14.05Evonik Receives the Trade Excellence Award in Alabama
14.05PPG Awards STEM Education Prizes to School Students in Poland
14.05Indorama Ventures Reports Improved Performance in 1Q 2024
13.05BASF in South Carolina Joins with Make-A-Wish
13.05Axalta to Acquire The CoverFlexx Group
Chemicals »
15.05Indian spices face heat over global safety concerns
15.05'Corrupt ship inspectors demand our food and cargo'
15.05Taylor Swift Eras Tour to boost UK spending by 1bn, says report
15.05Three ways to win the rental property race
15.05Renters in scrum for homes as listing time slashed
14.05Nu Skin Releases 2023 Social Impact and Sustainability Report
14.05P&G Unveils Plans to Feature Brands During the Olympic and Paralympic Games Paris 2024
14.05The LOccitane Group Appoints Evelyne LY-Wainer Managing Director Global Travel Retail
More »